Review





Similar Products

96
Proteintech arg1
Biological activity and plasma stability of substance P (SP). (A to C) TNF-α, IL-1β, and IL-6 concentrations in LPS-challenged RAW264.7 macrophages following treatment with graded SP concentrations. (D to F) TNF-α, IL-6, and IL-1β concentrations in LPS-challenged primary peritoneal macrophages following SP treatment. (G) Western blotting of iNOS and <t>Arg1</t> expression. (H and I) Densitometric quantification of iNOS and Arg1 protein levels. (J) CCK-8-based assessment of cell viability following treatment with graded SP concentrations. (K) Cell viability assay following incubation with plasma-exposed SP for different durations. Data are expressed as the mean ± SD ( n = 3). ns, not statistically significant; * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
Arg1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nnos/nNOS+Antibody/pmc13745762-45-8-12
Average 96 stars, based on 1 article reviews
arg1 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc nnos
Biological activity and plasma stability of substance P (SP). (A to C) TNF-α, IL-1β, and IL-6 concentrations in LPS-challenged RAW264.7 macrophages following treatment with graded SP concentrations. (D to F) TNF-α, IL-6, and IL-1β concentrations in LPS-challenged primary peritoneal macrophages following SP treatment. (G) Western blotting of iNOS and <t>Arg1</t> expression. (H and I) Densitometric quantification of iNOS and Arg1 protein levels. (J) CCK-8-based assessment of cell viability following treatment with graded SP concentrations. (K) Cell viability assay following incubation with plasma-exposed SP for different durations. Data are expressed as the mean ± SD ( n = 3). ns, not statistically significant; * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
Nnos, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nnos/nNOS+Antibody/pm42986380-126-51-53
Average 95 stars, based on 1 article reviews
nnos - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

93
ABclonal Biotechnology neuronal nitric oxide synthase
Biological activity and plasma stability of substance P (SP). (A to C) TNF-α, IL-1β, and IL-6 concentrations in LPS-challenged RAW264.7 macrophages following treatment with graded SP concentrations. (D to F) TNF-α, IL-6, and IL-1β concentrations in LPS-challenged primary peritoneal macrophages following SP treatment. (G) Western blotting of iNOS and <t>Arg1</t> expression. (H and I) Densitometric quantification of iNOS and Arg1 protein levels. (J) CCK-8-based assessment of cell viability following treatment with graded SP concentrations. (K) Cell viability assay following incubation with plasma-exposed SP for different durations. Data are expressed as the mean ± SD ( n = 3). ns, not statistically significant; * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
Neuronal Nitric Oxide Synthase, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nnos/NOS1+Rabbit+pAb/pm42868072-63-14-21
Average 93 stars, based on 1 article reviews
neuronal nitric oxide synthase - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
ABclonal Biotechnology nnos
Biological activity and plasma stability of substance P (SP). (A to C) TNF-α, IL-1β, and IL-6 concentrations in LPS-challenged RAW264.7 macrophages following treatment with graded SP concentrations. (D to F) TNF-α, IL-6, and IL-1β concentrations in LPS-challenged primary peritoneal macrophages following SP treatment. (G) Western blotting of iNOS and <t>Arg1</t> expression. (H and I) Densitometric quantification of iNOS and Arg1 protein levels. (J) CCK-8-based assessment of cell viability following treatment with graded SP concentrations. (K) Cell viability assay following incubation with plasma-exposed SP for different durations. Data are expressed as the mean ± SD ( n = 3). ns, not statistically significant; * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
Nnos, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nnos/NOS1+Rabbit+pAb/pm42546787-70-86-88
Average 93 stars, based on 1 article reviews
nnos - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
ABclonal Biotechnology anti nos1
Biological activity and plasma stability of substance P (SP). (A to C) TNF-α, IL-1β, and IL-6 concentrations in LPS-challenged RAW264.7 macrophages following treatment with graded SP concentrations. (D to F) TNF-α, IL-6, and IL-1β concentrations in LPS-challenged primary peritoneal macrophages following SP treatment. (G) Western blotting of iNOS and <t>Arg1</t> expression. (H and I) Densitometric quantification of iNOS and Arg1 protein levels. (J) CCK-8-based assessment of cell viability following treatment with graded SP concentrations. (K) Cell viability assay following incubation with plasma-exposed SP for different durations. Data are expressed as the mean ± SD ( n = 3). ns, not statistically significant; * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
Anti Nos1, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nnos/ALDOC+Rabbit+pAb/pm42731421-130-22-24
Average 93 stars, based on 1 article reviews
anti nos1 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
ABclonal Biotechnology ◦ c
Biological activity and plasma stability of substance P (SP). (A to C) TNF-α, IL-1β, and IL-6 concentrations in LPS-challenged RAW264.7 macrophages following treatment with graded SP concentrations. (D to F) TNF-α, IL-6, and IL-1β concentrations in LPS-challenged primary peritoneal macrophages following SP treatment. (G) Western blotting of iNOS and <t>Arg1</t> expression. (H and I) Densitometric quantification of iNOS and Arg1 protein levels. (J) CCK-8-based assessment of cell viability following treatment with graded SP concentrations. (K) Cell viability assay following incubation with plasma-exposed SP for different durations. Data are expressed as the mean ± SD ( n = 3). ns, not statistically significant; * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
◦ C, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nnos/NOS1+Rabbit+pAb/pm42731421-130-17-24
Average 93 stars, based on 1 article reviews
◦ c - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

96
Proteintech nnos
Biological activity and plasma stability of substance P (SP). (A to C) TNF-α, IL-1β, and IL-6 concentrations in LPS-challenged RAW264.7 macrophages following treatment with graded SP concentrations. (D to F) TNF-α, IL-6, and IL-1β concentrations in LPS-challenged primary peritoneal macrophages following SP treatment. (G) Western blotting of iNOS and <t>Arg1</t> expression. (H and I) Densitometric quantification of iNOS and Arg1 protein levels. (J) CCK-8-based assessment of cell viability following treatment with graded SP concentrations. (K) Cell viability assay following incubation with plasma-exposed SP for different durations. Data are expressed as the mean ± SD ( n = 3). ns, not statistically significant; * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
Nnos, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nnos/nNOS+Antibody/10__31083_slash_ijp48017-74-12-42
Average 96 stars, based on 1 article reviews
nnos - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

86
Servicebio Inc anti nos1
Biological activity and plasma stability of substance P (SP). (A to C) TNF-α, IL-1β, and IL-6 concentrations in LPS-challenged RAW264.7 macrophages following treatment with graded SP concentrations. (D to F) TNF-α, IL-6, and IL-1β concentrations in LPS-challenged primary peritoneal macrophages following SP treatment. (G) Western blotting of iNOS and <t>Arg1</t> expression. (H and I) Densitometric quantification of iNOS and Arg1 protein levels. (J) CCK-8-based assessment of cell viability following treatment with graded SP concentrations. (K) Cell viability assay following incubation with plasma-exposed SP for different durations. Data are expressed as the mean ± SD ( n = 3). ns, not statistically significant; * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
Anti Nos1, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nnos/anti+nos1/pm42052385-57-0-22
Average 86 stars, based on 1 article reviews
anti nos1 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Jackson Laboratory nos1 ires cre mice
Biological activity and plasma stability of substance P (SP). (A to C) TNF-α, IL-1β, and IL-6 concentrations in LPS-challenged RAW264.7 macrophages following treatment with graded SP concentrations. (D to F) TNF-α, IL-6, and IL-1β concentrations in LPS-challenged primary peritoneal macrophages following SP treatment. (G) Western blotting of iNOS and <t>Arg1</t> expression. (H and I) Densitometric quantification of iNOS and Arg1 protein levels. (J) CCK-8-based assessment of cell viability following treatment with graded SP concentrations. (K) Cell viability assay following incubation with plasma-exposed SP for different durations. Data are expressed as the mean ± SD ( n = 3). ns, not statistically significant; * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
Nos1 Ires Cre Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nnos/cre+vglut2/pmc13143026-222-2-7
Average 86 stars, based on 1 article reviews
nos1 ires cre mice - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results


Biological activity and plasma stability of substance P (SP). (A to C) TNF-α, IL-1β, and IL-6 concentrations in LPS-challenged RAW264.7 macrophages following treatment with graded SP concentrations. (D to F) TNF-α, IL-6, and IL-1β concentrations in LPS-challenged primary peritoneal macrophages following SP treatment. (G) Western blotting of iNOS and Arg1 expression. (H and I) Densitometric quantification of iNOS and Arg1 protein levels. (J) CCK-8-based assessment of cell viability following treatment with graded SP concentrations. (K) Cell viability assay following incubation with plasma-exposed SP for different durations. Data are expressed as the mean ± SD ( n = 3). ns, not statistically significant; * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

Journal: Biomaterials Research

Article Title: A Chitosan-Based Neuropeptide Hydrogel with Zinc Oxide-Assisted Antioxidant Activity for Ultraviolet B-Induced Delayed Wound Repair

doi: 10.34133/bmr.0443

Figure Lengend Snippet: Biological activity and plasma stability of substance P (SP). (A to C) TNF-α, IL-1β, and IL-6 concentrations in LPS-challenged RAW264.7 macrophages following treatment with graded SP concentrations. (D to F) TNF-α, IL-6, and IL-1β concentrations in LPS-challenged primary peritoneal macrophages following SP treatment. (G) Western blotting of iNOS and Arg1 expression. (H and I) Densitometric quantification of iNOS and Arg1 protein levels. (J) CCK-8-based assessment of cell viability following treatment with graded SP concentrations. (K) Cell viability assay following incubation with plasma-exposed SP for different durations. Data are expressed as the mean ± SD ( n = 3). ns, not statistically significant; * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

Article Snippet: Antibodies against inducible nitric oxide synthase (iNOS) and Arg1 were purchased from Proteintech.

Techniques: Activity Assay, Clinical Proteomics, Stability, Western Blot, Expressing, CCK-8 Assay, Cell Viability Assay, Incubation

Macrophage phenotype regulation by the CS-SP-Nap-β@ZnO hydrogel. (A and B) TNF-α and IL-6 levels in LPS-challenged macrophages after the indicated treatments. (C) F-actin cytoskeletal staining of RAW264.7 macrophages after LPS stimulation and treatment with IL-4, SP, CS-Nap-β, CS-SP-Nap-β, or CS-SP-Nap-β@ZnO. Scale bar, 20 μm. (D) Immunofluorescence staining for CD206. Scale bar, 50 μm. (E) Immunofluorescence staining for Arg1. Scale bar, 50 μm. (F and G) Quantification of CD206 and Arg1 fluorescence intensity. (H) Representative flow cytometry plots of CD11b and CD86 expression in LPS-stimulated macrophages following different treatments. (I) Quantification of the proportion of CD86 + macrophages. (J) Quantification of CD86 median fluorescence intensity. (K) Representative flow cytometry plots of CD206 and CD163 expression in LPS-stimulated macrophages following different treatments. (L) Quantification of the proportion of CD206 + CD163 + macrophages. (M) Quantification of CD206 median fluorescence intensity. Data are expressed as the mean ± SD ( n = 3). ns, not statistically significant; * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

Journal: Biomaterials Research

Article Title: A Chitosan-Based Neuropeptide Hydrogel with Zinc Oxide-Assisted Antioxidant Activity for Ultraviolet B-Induced Delayed Wound Repair

doi: 10.34133/bmr.0443

Figure Lengend Snippet: Macrophage phenotype regulation by the CS-SP-Nap-β@ZnO hydrogel. (A and B) TNF-α and IL-6 levels in LPS-challenged macrophages after the indicated treatments. (C) F-actin cytoskeletal staining of RAW264.7 macrophages after LPS stimulation and treatment with IL-4, SP, CS-Nap-β, CS-SP-Nap-β, or CS-SP-Nap-β@ZnO. Scale bar, 20 μm. (D) Immunofluorescence staining for CD206. Scale bar, 50 μm. (E) Immunofluorescence staining for Arg1. Scale bar, 50 μm. (F and G) Quantification of CD206 and Arg1 fluorescence intensity. (H) Representative flow cytometry plots of CD11b and CD86 expression in LPS-stimulated macrophages following different treatments. (I) Quantification of the proportion of CD86 + macrophages. (J) Quantification of CD86 median fluorescence intensity. (K) Representative flow cytometry plots of CD206 and CD163 expression in LPS-stimulated macrophages following different treatments. (L) Quantification of the proportion of CD206 + CD163 + macrophages. (M) Quantification of CD206 median fluorescence intensity. Data are expressed as the mean ± SD ( n = 3). ns, not statistically significant; * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

Article Snippet: Antibodies against inducible nitric oxide synthase (iNOS) and Arg1 were purchased from Proteintech.

Techniques: Cytoskeletal, Staining, Immunofluorescence, Fluorescence, Flow Cytometry, Expressing